Germany’s University Medical Center Mannheim Accelerates Cancer Care with Elekta’s Monaco Planning Software
March 31, 2010 by Prostate Dr. · Comments Off
Immunovaccine Begins Patient Recruitment For Phase 1 Trial Of DPX-0907 Cancer Vaccine
Immunovaccine Inc. (TSX VENTURE:IMV) announced that it has started screening patients for its Phase 1 clinical trial, investigating the company’s therapeutic cancer vaccine, DPX-0907, as a treatment for patients with advanced stage breast, ovarian and prostate cancer. The primary goal of the trial is to establish the safety of the vaccine candidate which includes the DepoVax™ delivery platform …
Read…
»»Read more: Germany’s University Medical Center Mannheim Accelerates Cancer Care with Elekta’s Monaco Planning Software